Today's pharmaceutical market is facing the challenges of inflation, government-imposed drug price caps and waning demand for ...

The ability to plan several steps ahead and promptly adapt to a rapidly changing environment is essential to being an elite ...

A neuroimaging study of torture survivors found that these individuals exhibit decreased connectivity in brain networks ...

We are thrilled to welcome Matt to Verastem Oncology at an important time as we prepare for a mid-2025 product launch and the transition into a commercial-stage company, while we continue to advance ...

A new study showed that SOCS1 regulation of GM-CSF signaling is dose-dependent. The study, which involved generating a novel ...

Both HFDs and high-sugar diets (HSDs) increase impulsive behavior. Prior research suggests that HFDs may increase ...

First subjects dosed in a Phase 2 trial of VTX3232 in participants with obesity and cardiometabolic risk factors, with topline data expected in ...

The participants were categorized as early childhood-onset asthma (asthma at baseline and follow-up), later childhood-onset ...

For children with severe hypertrophic cardiomyopathy caused by gain-of-function RAS/mitogen-activated protein kinase ( ...

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.

Eli Lilly is reenergizing its attempt to challenge Novartis and Roche for a breast cancer market, kicking off the J.P. Morgan ...

Upcoming Investor Conference Skye Bioscience will be a corporate presenter at the 43 rd annual J.P. Morgan Healthcare Conference Thursday, January 16, 2025, at 10:30 AM - 11:10 AM and is available for ...